Hiroshi Katayama Selected Research

CF regimen

5/2015

A randomized controlled Phase III trial comparing 2-weekly docetaxel combined with cisplatin plus fluorouracil (2-weekly DCF) with cisplatin plus fluorouracil (CF) in patients with metastatic or recurrent esophageal cancer: rationale, design and methods of Japan Clinical Oncology Group study JCOG1314 (MIRACLE study).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroshi Katayama Research Topics

Disease

29	Neoplasms (Cancer) 01/2022 - 12/2003
22	Stomach Neoplasms (Stomach Cancer) 03/2021 - 01/2009
9	Neoplasm Metastasis (Metastasis) 12/2021 - 01/2008
7	Lymphatic Metastasis 01/2022 - 06/2012
7	Colorectal Neoplasms (Colorectal Cancer) 12/2021 - 09/2014
6	Adenocarcinoma 01/2022 - 02/2014
6	Esophageal Neoplasms (Esophageal Cancer) 12/2017 - 04/2007
6	Chromosomal Instability (Chromosome Stability) 01/2016 - 09/2002
5	Rectal Neoplasms (Rectal Cancer) 01/2022 - 01/2017
5	Infections 01/2021 - 05/2004
5	Carcinogenesis 01/2020 - 09/2002
4	Esophageal Squamous Cell Carcinoma 12/2021 - 01/2016
4	Inflammation (Inflammations) 10/2021 - 11/2005
4	Breast Neoplasms (Breast Cancer) 12/2016 - 01/2004
4	Carcinoma (Carcinomatosis) 04/2014 - 04/2007
4	Hemorrhagic Shock 07/2010 - 02/2008
3	Neutropenia 12/2021 - 03/2017
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2021 - 09/2007
3	Lung Neoplasms (Lung Cancer) 09/2020 - 09/2007
3	Genomic Instability 01/2016 - 01/2008
2	Cardiac Arrhythmias (Arrythmia) 11/2021 - 09/2002
2	Hypoxia (Hypoxemia) 11/2021 - 03/2009
2	Pancreatic Neoplasms (Pancreatic Cancer) 02/2021 - 10/2018
2	Residual Neoplasm 01/2021 - 07/2015
2	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 03/2010
2	Glioblastoma (Glioblastoma Multiforme) 12/2019 - 07/2018
2	Linitis Plastica 11/2019 - 01/2019
2	Leukopenia 01/2019 - 03/2017
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2018 - 04/2014
2	Hyponatremia 01/2018 - 03/2017
2	Asthma (Bronchial Asthma) 01/2018 - 06/2017
2	Pneumonia (Pneumonitis) 01/2017 - 07/2010
2	Pathologic Constriction (Stenosis) 04/2015 - 05/2006
2	Hyperglycemia 03/2010 - 04/2007
2	Critical Illness (Critically Ill) 03/2010 - 01/2006
2	Abdominal Aortic Aneurysm 06/2009 - 06/2009
2	Urinary Bladder Neoplasms (Bladder Cancer) 10/2008 - 01/2004
2	Acute Liver Failure (Fulminant Hepatic Failure) 01/2008 - 04/2002
2	Wounds and Injuries (Trauma) 10/2006 - 08/2004
1	Hypersensitivity (Allergy) 12/2021

Drug/Important Bio-Agent (IBA)

12	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 06/2012
10	Aurora Kinase AIBA 12/2016 - 01/2004
7	Fluorouracil (Carac)FDA LinkGeneric 01/2022 - 01/2015
6	Docetaxel (Taxotere)FDA Link 02/2020 - 06/2012
5	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 01/2017
5	Leucovorin (Folinic Acid)FDA Link 01/2022 - 01/2017
5	Phosphotransferases (Kinase)IBA 04/2011 - 12/2003
4	S-1 plus cisplatinIBA 03/2021 - 11/2015
4	Irinotecan (Camptosar)FDA LinkGeneric 11/2019 - 04/2014
4	Aurora KinasesIBA 01/2016 - 12/2003
4	Heme Oxygenase-1IBA 01/2009 - 08/2004
3	Interleukin-17 (Interleukin 17)IBA 10/2021 - 06/2017
3	Gemcitabine FDA Link 02/2021 - 04/2016
3	Codon (Codons)IBA 11/2020 - 01/2016
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 10/2008
3	Proteins (Proteins, Gene)FDA Link 12/2016 - 01/2016
3	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 04/2011 - 09/2009
3	Estrogen ReceptorsIBA 04/2011 - 09/2007
3	Angiotensin IIIBA 06/2009 - 07/2006
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2009 - 02/2004
2	Ethanol (Ethyl Alcohol)IBA 11/2020 - 01/2016
2	AntibodiesIBA 01/2020 - 10/2018
2	Temozolomide (Temodar)FDA LinkGeneric 12/2019 - 07/2018
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 03/2009
2	Pharmaceutical PreparationsIBA 12/2018 - 02/2018
2	leucylarginineIBA 02/2017 - 01/2016
2	Trastuzumab (Herceptin)FDA Link 11/2015 - 02/2014
2	Estrogens (Estrogen)FDA Link 04/2011 - 02/2010
2	Interleukin-10 (Interleukin 10)IBA 07/2010 - 01/2009
2	Peroxidase (Myeloperoxidase)IBA 07/2010 - 01/2009
2	Messenger RNA (mRNA)IBA 07/2010 - 02/2004
2	Carbon MonoxideIBA 07/2010 - 01/2006
2	AndrogensIBA 03/2010 - 01/2008
2	isomaltulose (palatinose)IBA 03/2010 - 04/2007
2	Insulin (Novolin)FDA Link 03/2010 - 09/2002
2	EnzymesIBA 06/2009 - 10/2006
2	Chymases (Chymase)IBA 06/2009 - 07/2006
2	LipopolysaccharidesIBA 02/2009 - 02/2004
2	Caspase 3 (Caspase-3)IBA 01/2009 - 02/2008
2	oprelvekin (Neumega)FDA Link 10/2006 - 02/2004
2	Heme (Haem)IBA 10/2006 - 01/2006
2	Interleukin-11 (Interleukin 11)IBA 10/2006 - 02/2004
2	DNA (Deoxyribonucleic Acid)IBA 02/2004 - 01/2004
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 11/2021

Therapy/Procedure

21	Drug Therapy (Chemotherapy) 01/2022 - 06/2012
18	Therapeutics 09/2020 - 04/2002
13	Gastrectomy 03/2021 - 01/2009
8	Lymph Node Excision (Lymph Node Dissection) 01/2022 - 01/2009
8	Adjuvant Chemotherapy 12/2021 - 04/2014
8	Esophagectomy 12/2015 - 11/2005
7	Chemoradiotherapy 12/2021 - 12/2015
4	Neoadjuvant Therapy 03/2021 - 01/2015
4	Ligation 09/2014 - 09/2002
3	Radiotherapy 01/2019 - 04/2016
2	Colectomy 01/2022 - 09/2014
2	Segmental Mastectomy (Lumpectomy) 09/2020 - 05/2017
2	General Anesthesia 08/2010 - 01/2006
2	Catheters 10/2007 - 04/2003
2	Liver Transplantation 09/2002 - 04/2002
1	Hepatectomy 12/2021